The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment-Reference-Cited by-同舟云学术

The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment

Published:2002-09 Issue:3 Volume:95 Page:544-551
ISSN:0003-2999
Container-title:Anesthesia & Analgesia
language:en
Short-container-title:Anesthesia & Analgesia

Author:

Jungheinrich Cornelius,Scharpf Roland,Wargenau Manfred,Bepperling Frank,Baron Jean-Fran??ois

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Reference27 articles.

1. Intestinal elimination of hydroxyethyl starch?

2. PLA2 antagonists suppress inducible nitric oxide synthase and inducible cyclooxygenase in lipopolysaccharide-induced Raw264.7 cells

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in the degree of substitution of HES in vivo and their influence on methods for determining HES concentrations in plasma;PLOS ONE;2023-08-22

2. The effects of hydroxyethyl starch 130/0.4 on perioperative renal function in patients undergoing cardiac surgery: A randomised controlled trial;Annals of Medicine & Surgery;2022-09

3. Clinical Outcomes and Medical Costs of Hydration Therapy with Hydroxyethyl Starch (130/0.4) or Acute Single Infarction;Journal of Stroke and Cerebrovascular Diseases;2021-05

4. Effects of hydroxyethyl starch and gelatin on the risk of acute kidney injury following orthotopic liver transplantation: A multicenter retrospective comparative clinical study;Open Medicine;2021-01-01

5. Evaluation of the Distribution and Elimination of Balanced Isotonic Crystalloid, 5% Hypertonic Saline, and 6% Tetrastarch 130/0.4 Using Volume Kinetic Modeling and Analysis in Healthy Conscious Cats;Frontiers in Veterinary Science;2020-11-13